Clinical trial for Ebola vaccine developed at UW–Madison underway in Japan

As of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of the experimental vaccine. If the first group tolerates the vaccine, an additional group of up to 20 volunteers will receive a higher dose of the vaccine.

UW-Madison brain scan studies seek to pinpoint signs of Alzheimer’s

Waisman Center investigator Brad Christian and Waisman Center affiliates Sterling Johnson and Barbara Bendlin were featured in a Nov. 26 Wisconsin State
Journal article this week about Alzheimer’s research. The article is a part of a series on Alzheimer’s called “Fading away: Wisconsin’s dementia crisis,” which chronicles the doubling rate of dementia patients in Wisconsin.

Time-to-degree improves again, setting record

Undergraduates at the University of Wisconsin–Madison are taking less time to complete their degrees, setting a record on a key measure of student success. The average time-to-degree for 2018-19 bachelor’s degree recipients was 3.96 elapsed calendar years, the lowest since the university began actively tracking the measure in the 1980s and the first time the number has dropped below four years, according to the university’s Office of Academic Planning and Institutional Research.